Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Apr;114(4):493-8.
doi: 10.1111/j.1365-2567.2004.02113.x.

Complement receptors regulate lipopolysaccharide-induced T-cell stimulation

Affiliations

Complement receptors regulate lipopolysaccharide-induced T-cell stimulation

Ziya Kaya et al. Immunology. 2005 Apr.

Abstract

Complement receptors type 1 and 2 (CR1 (CD35)/CR2 (CD21)) are known to enhance the adaptive immune response. In mice, CR1/CR2 are expressed on B cells, follicular dendritic cells, and activated granulocytes. Recently, we showed that a subset of CD44high and CD62Llow T cells also expresses CR1 and CR2. We now report that CR1/CR2 are detectable on both CD4+ and CD8+ subsets of T cells. Lipopolysaccharide (LPS) from Gram-negative bacteria causes polyclonal activation of B cells and stimulation of macrophages and other antigen-presenting cells. We further demonstrate that LPS induced marked up-regulation of CD25 and CD69 on T cells from CR1/CR2 sufficient (Cr+/+), but significantly lower up-regulation on T cells from CR1/CR2 deficient (Cr-/-) mice. These findings point to a novel mechanism by which CR1/CR2 modulates the activation of T cells by LPS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expression of CR1/CR2 on a subset of CD4+ and CD8+ T cells. Triple staining of splenocytes from Cr+/+ mice was performed using PE-labelled anti-CD3, FITC-labelled anti-CR1/CR2, and cytochrome-labelled anti-CD4 or anti-CD8. Numbers present the percentage of CD3+, CD4+ or CD8+ cells staining with the indicated marker Density plot.
Figure 2
Figure 2
Expression of CD69 on Cr+/+ or CR–/– T cells. Splenocytes from immunized Cr+/+ and Cr–/– mice were cultured in the presence of 25 µg/ml LPS, plate-bound anti-CD3 antibodies, or medium alone for 24 hr followed by FACScan analysis for the expression of CD69 on T cells. Numbers present the percentage of CD3+ cells staining with the indicated marker Dotplot. *P < 0·05.
Figure 3
Figure 3
Expression of CD25 and CD69 on CD3+ T cells. Splenocytes from immunized wild type mice were cultured in the presence of 10 µg/ml, 25 µg/ml or 100 µg/ml LPS or no antibody (medium), 100 µg/ml control antibody or 100 µg/ml 7G6 mAb for 24 hr followed by FACScan analysis for the expression of CD25 and CD69 on T cells. Numbers present the percentage of CD3+ cells staining with the indicated marker. *P < 0·05.
Figure 4
Figure 4
Expression of CD69 and CD25 on T cells in culture with macrophages. Numbers present the percentage of CD3+ cells staining with the indicated marker; T, T cells; Mac, macrophages. *P < 0·05.

Similar articles

Cited by

References

    1. Kinoshita T, Takeda J, Hong K, Kozono H, Sakai H, Inoue K. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol. 1988;140:3066–72. - PubMed
    1. Kaya Z, Afanasyeva M, Wang Y, et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol. 2001;2:739–45. 10.1038/90686. - DOI - PubMed
    1. Molina H, Holers VM, Li B, et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA. 1996;93:3357–61. 10.1073/pnas.93.8.3357. - DOI - PMC - PubMed
    1. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 1996;271:348–50. - PubMed
    1. Fang Y, Xu C, Fu YX, Holers VM, Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol. 1998;160:5273–9. - PubMed

Publication types

MeSH terms

LinkOut - more resources